Reduced antibiotics due to rapid diagnostics

Horizon-2020-square[1].jpg

The international research project, PERFORM, will receive 18M Euro to further research on the rapid diagnosis of infections.  The PERFORM grant is one of the largest awarded by the European Commission’s Horizon 2020 Health Programme in 2016 and aims to bring novel new diagnostics into clinical use and improve management of febrile children within the five year period.

A study, involving more than 50,000 children, has led to a rapid test that could reduce the use of antibiotics.  The hope is that this project will not only allow medical staff to reduce the number of unnecessary antibiotics - but it could also quickly identify deadly cases of meningitis, sepsis and other life-threatening bacterial infections.

During the five year project, the international team will study around 60,000 children who arrive at hospitals across Europe and West Africa with fever. The team includes groups from Oxford, Liverpool,  Newcastle, Spain, Austria, Germany, The Netherlands, Greece, Slovenia, Latvia , the Gambia and Switzerland, as well as the biotechnology companies Micropathology Ltd UK and bioMérieux, France.

The Dutch contribution to this research is carried out by the Radboudumc, Amsterdam MC and Erasmus MC. From the Radboudumc several groups are involved: Ronald de Groot, Marien de Jonge and Michiel van der Flier, Alain van Gool and Jolein Gloerich, Martijn Huijnen and Wynand Alkema. In total Radboudumc will receive 1.5M Euro.

 Ronald de Groot undefined undefined 

Ronald de Groot                      Marien de Jonge                     Michiel van der Flier     

undefinedundefined

Alain van Gool                       Jolein Gloerich 

undefined undefinedundefinedundefinedundefined

Martijn Huijnen                        Wijnand Alkema




<< back to overview news items